Clinical Utility of the MDASI-BT in Patients with Brain Metastases Terri S. Armstrong, PhD, Ibrahima Gning, DrPH, Tito R. Mendoza, PhD, Jeffrey S. Weinberg, MD, Mark R. Gilbert, MD, Melissa L. Tortorice, BS, Charles S. Cleeland, PhD  Journal of Pain and Symptom Management  Volume 37, Issue 3, Pages 331-340 (March 2009) DOI: 10.1016/j.jpainsymman.2008.02.011 Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 Cluster analysis of the MDASI-BT symptoms with dendrogram (n=124). Distances between symptom scores as rated by patients were calculated using squared Euclidian distances to form clusters of symptoms. Graphical displays with dendrograms showing cohesion between clusters were done using Ward's method. Shaded areas represent the commonly seen patterns of gastrointestinal and affective clusters as described in other symptom validation studies. Journal of Pain and Symptom Management 2009 37, 331-340DOI: (10.1016/j.jpainsymman.2008.02.011) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 2 Symptom severity by good (90–100) versus poor (30–80) KPS (n=124). Note: Mean differences are not significant for nausea, vomiting, seizures, and change in bowel patterns. Journal of Pain and Symptom Management 2009 37, 331-340DOI: (10.1016/j.jpainsymman.2008.02.011) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions